Use access key #2 to skip to page content.

inthemoneystock (< 20)

IBM On Steroids: A Case Of A Bubble Market

Recs

0

May 16, 2013 – Comments (0) | RELATED TICKERS: IBM

International Business Machines Corp.(NYSE:IBM) is surging again today, trading at $205.95, +2.63 (1.29%). The stock reported ugly earnings three weeks ago and collapsed to a low of $187.68. This was a massive decline and thought to be the end of an era for this tech titan. Yet, today IBM has risen from the dead. Charge higher, juiced on steroids from a market where investor are chasing return and even ugly earnings and outlook looks attractive. The Federal Reserve has artificially deflated yields forcing investors to turn to the only place they can for any sort of return. The stock market. As the bubble inflates, it no longer matters what the earnings, revenues or future projections were. If it is a stock, buy it. That is the mentality of this bubble market. How do you trade it? Ride it while it lasts but be wary. The market often takes the stairs higher and the elevator down.

Gareth Soloway
InTheMoneyStocks.com

0 Comments – Post Your Own

Featured Broker Partners


Advertisement